Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales.

IF 4 2区 社会学 Q1 SUBSTANCE ABUSE
Courtney R Yarbrough, Nora Jaquemet, Siara I Sitar, Maggie J Mataczynski, Vega Walke, Natalie D Crawford, Henry N Young, Justine W Welsh
{"title":"Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales.","authors":"Courtney R Yarbrough, Nora Jaquemet, Siara I Sitar, Maggie J Mataczynski, Vega Walke, Natalie D Crawford, Henry N Young, Justine W Welsh","doi":"10.1186/s12954-025-01280-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Numerous states, including Georgia in April 2019, have advanced policies designed to increase availability of sterile syringes in pharmacies for people who inject drugs (PWID); however, the extent to which pharmacies are willing to sell syringes to PWID is unclear. We examine sterile syringes sales practices in Georgia pharmacies to PWID following a recent policy change and pharmacists' cited reasons for these practices.</p><p><strong>Methods: </strong>We conducted a telephone survey from October 2020 through May 2021 of one pharmacist (staff or manager) per pharmacy in a sample of Georgia retail pharmacies stratified by urbanicity. The 15-question survey queried respondents about the pharmacy's current practices regarding nonprescription sterile syringe sales and the respondents' perceptions of syringe sales and counseling practices to those purchasing syringes. Pharmacy and pharmacist demographics were collected and correlations between these characteristics were estimated using unadjusted logistic regression models.</p><p><strong>Results: </strong>We obtained responses from 119 pharmacies (response rate = 34%). Most surveyed pharmacies (81%) reported that they did not sell syringes to patients without a prescription for nonmedical uses, including intravenous drug use. There were no differences in whether pharmacies were more or less likely to sell syringes by level of urbanicity, local poverty rate, local racial/ethnic composition, or pharmacy type (i.e., chain vs. independently owned). The most common reasons cited for not selling syringes were security concerns, that syringe sales encourage drug use, and corporate policy. Among pharmacists in pharmacies not currently selling syringes, only 54% of were aware of the state law change allowing sales of syringes without a medical reason.</p><p><strong>Conclusions: </strong>Despite an important policy change advancing harm reduction through sterile syringe access, availability of sterile syringes to PWID in Georgia pharmacies was likely still hampered by lack of dispensing by pharmacies. Implementation efforts following important policy changes-including building awareness of the new policy, encouraging support of harm reduction efforts, and continuing education around substance use disorders-are essential for achieving the intended outcomes of the policy.</p>","PeriodicalId":12922,"journal":{"name":"Harm Reduction Journal","volume":"22 1","pages":"139"},"PeriodicalIF":4.0000,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357477/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harm Reduction Journal","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1186/s12954-025-01280-2","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Numerous states, including Georgia in April 2019, have advanced policies designed to increase availability of sterile syringes in pharmacies for people who inject drugs (PWID); however, the extent to which pharmacies are willing to sell syringes to PWID is unclear. We examine sterile syringes sales practices in Georgia pharmacies to PWID following a recent policy change and pharmacists' cited reasons for these practices.

Methods: We conducted a telephone survey from October 2020 through May 2021 of one pharmacist (staff or manager) per pharmacy in a sample of Georgia retail pharmacies stratified by urbanicity. The 15-question survey queried respondents about the pharmacy's current practices regarding nonprescription sterile syringe sales and the respondents' perceptions of syringe sales and counseling practices to those purchasing syringes. Pharmacy and pharmacist demographics were collected and correlations between these characteristics were estimated using unadjusted logistic regression models.

Results: We obtained responses from 119 pharmacies (response rate = 34%). Most surveyed pharmacies (81%) reported that they did not sell syringes to patients without a prescription for nonmedical uses, including intravenous drug use. There were no differences in whether pharmacies were more or less likely to sell syringes by level of urbanicity, local poverty rate, local racial/ethnic composition, or pharmacy type (i.e., chain vs. independently owned). The most common reasons cited for not selling syringes were security concerns, that syringe sales encourage drug use, and corporate policy. Among pharmacists in pharmacies not currently selling syringes, only 54% of were aware of the state law change allowing sales of syringes without a medical reason.

Conclusions: Despite an important policy change advancing harm reduction through sterile syringe access, availability of sterile syringes to PWID in Georgia pharmacies was likely still hampered by lack of dispensing by pharmacies. Implementation efforts following important policy changes-including building awareness of the new policy, encouraging support of harm reduction efforts, and continuing education around substance use disorders-are essential for achieving the intended outcomes of the policy.

Abstract Image

Abstract Image

Abstract Image

尽管政策改变允许销售,但在佐治亚州的药房,无菌注射器的供应仍然很少。
背景:许多州,包括2019年4月的格鲁吉亚,都制定了先进的政策,旨在增加药房为注射吸毒者提供无菌注射器(PWID);然而,药店愿意向PWID出售注射器的程度尚不清楚。我们检查无菌注射器销售做法在格鲁吉亚药店PWID以下最近的政策变化和药剂师引用这些做法的原因。方法:从2020年10月到2021年5月,我们在佐治亚州按城市化程度分层的零售药店样本中对每家药房的一名药剂师(员工或经理)进行了电话调查。这个15个问题的调查询问了受访者关于药房目前关于非处方无菌注射器销售的做法,以及受访者对注射器销售和对购买注射器的咨询做法的看法。收集药房和药剂师的人口统计数据,并使用未经调整的逻辑回归模型估计这些特征之间的相关性。结果:共获得119家药店的反馈,反馈率为34%。大多数接受调查的药房(81%)报告说,他们不向没有处方的患者出售注射器,用于非医疗用途,包括静脉注射药物。根据城市化程度、当地贫困率、当地种族/民族构成或药店类型(即连锁药店与独立药店),药店销售注射器的可能性或多或少没有差异。不销售注射器的最常见原因是安全问题,注射器销售鼓励吸毒,以及公司政策。在目前不销售注射器的药店的药剂师中,只有54%的人知道州法律的变化,允许在没有医疗原因的情况下销售注射器。结论:尽管通过获得无菌注射器促进减少危害的重要政策变化,但佐治亚州药房对PWID的无菌注射器的可获得性可能仍然受到药房配药不足的阻碍。重要政策变化后的实施工作——包括建立对新政策的认识,鼓励支持减少伤害的努力,以及围绕药物使用障碍的继续教育——对于实现政策的预期结果至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Harm Reduction Journal
Harm Reduction Journal Medicine-Public Health, Environmental and Occupational Health
CiteScore
5.90
自引率
9.10%
发文量
126
审稿时长
26 weeks
期刊介绍: Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信